The EXT2 Gene Exostoses Multiple Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the EXT2 gene, which are associated with Hereditary Multiple Exostoses (HME) type 2. Hereditary Multiple Exostoses is a genetic disorder characterized by the growth of multiple benign bone tumors or exostoses, which can lead to pain, deformity, and, in some cases, an increased risk of malignant transformation. The EXT2 gene plays a crucial role in bone growth and development, and mutations in this gene can disrupt normal skeletal development, leading to the symptoms associated with HME.
This test is crucial for individuals with a family history of HME or those displaying symptoms consistent with the disorder, as it allows for an accurate diagnosis, guiding treatment and management decisions. Additionally, it can provide valuable information for family planning, offering insights into the risk of passing the condition on to future generations.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the EXT2 gene. DNA Labs UAE, known for its advanced genetic testing capabilities and stringent quality standards, conducts this test.
The cost of the EXT2 Gene Exostoses Multiple Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the test, including the expertise required to accurately identify and interpret genetic mutations. For individuals at risk of HME or those seeking a definitive diagnosis, this test represents a critical step towards managing the condition effectively.
The ERCC4 gene, also known as the Fanconi anemia complementation group Q gene, plays a crucial role in DNA repair processes, particularly in the repair of DNA crosslinks. Mutations in this gene can lead to Fanconi anemia (FA), a rare genetic disorder characterized by bone marrow failure, increased cancer risk, and physical abnormalities. The condition follows an autosomal recessive inheritance pattern, meaning that two copies of the mutated gene, one from each parent, are required for the disease to manifest.
To diagnose and manage Fanconi anemia effectively, genetic testing for mutations in the ERCC4 gene and other related genes is essential. In the United Arab Emirates, DNA Labs UAE offers a comprehensive genetic test for the ERCC4 gene to identify mutations associated with Fanconi anemia complementation group Q. This test is a valuable tool for individuals with a family history of the disorder, those exhibiting symptoms, or couples planning a family who wish to assess their risk of passing the condition to their offspring.
The cost of the ERCC4 gene Fanconi anemia complementation group Q genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing it in the laboratory for the presence of mutations in the ERCC4 gene. The results can provide crucial information for diagnosis, treatment planning, and genetic counseling, helping affected individuals and their families make informed health and reproductive decisions.
The MIR17HG gene, associated with Feingold syndrome type 2, is a critical focus for genetic testing at DNA Labs UAE. Feingold syndrome type 2 is a rare genetic disorder characterized by various anomalies, including digital and gastrointestinal abnormalities. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one copy of the gene in each cell is sufficient to cause the disorder.
DNA Labs UAE offers a specialized genetic test to identify mutations in the MIR17HG gene, providing essential information for the diagnosis, management, and genetic counseling of affected families. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations associated with Feingold syndrome type 2.
The cost of the MIR17HG gene test for Feingold syndrome type 2 at DNA Labs UAE is 4400 AED. This comprehensive test is a valuable tool for families seeking answers about this rare condition, enabling them to make informed decisions about their health and future.
The LAMC2 gene plays a pivotal role in skin structure and integrity, and mutations in this gene can lead to a severe genetic disorder known as Junctional Epidermolysis Bullosa (JEB). This condition is characterized by extremely fragile skin that blisters and tears from minor friction or trauma. JEB is a result of faulty or missing components in the skin layers that are crucial for binding the epidermis to the underlying dermis.
To diagnose this condition, genetic testing of the LAMC2 gene is available at DNA Labs UAE. This test is crucial for confirming the diagnosis of Junctional Epidermolysis Bullosa, enabling early intervention, and providing essential information for family planning. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, and examining the LAMC2 gene for specific mutations known to cause JEB.
The cost of the LAMC2 gene Epidermolysis Bullosa Junctional Genetic Test at DNA Labs UAE is 4400 AED. This test is a vital tool for individuals with a family history of JEB or those exhibiting symptoms, offering them a clear diagnosis and the possibility to seek appropriate treatment and support.
The LAMA3 gene plays a critical role in the development and maintenance of the skin's structural integrity. Mutations in this gene are associated with Junctional Epidermolysis Bullosa (JEB) of the Herlitz type, a severe genetic disorder characterized by blister formation within the skin and mucous membranes at sites of minor injury or friction. This condition is inherited in an autosomal recessive pattern, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent, for the disease to manifest.
To diagnose this condition, genetic testing of the LAMA3 gene is available. This test is crucial for confirming the diagnosis, understanding the disease's severity, and informing family planning decisions. In the United Arab Emirates, DNA Labs UAE offers this specific genetic test. The cost of the test is 4400 AED, a price that reflects the sophisticated technology and expertise required to accurately identify mutations in the LAMA3 gene. Conducted in a state-of-the-art laboratory by skilled geneticists, this test provides essential information for affected families, helping them navigate the challenges associated with Junctional Epidermolysis Bullosa Herlitz type.
The LAMB3 gene is crucial for encoding the laminin-332 protein, which plays a significant role in anchoring the epidermis to the underlying dermis, thus ensuring skin integrity and strength. Mutations in the LAMB3 gene can lead to a severe form of Junctional Epidermolysis Bullosa (JEB), known as the Herlitz type. This genetic disorder is characterized by fragile skin that easily blisters and wounds, affecting both the skin and mucous membranes. It is a life-threatening condition often evident from birth.
To diagnose this condition accurately, genetic testing for mutations in the LAMB3 gene is essential. DNA Labs UAE offers a specialized test designed to identify these mutations, thereby confirming the diagnosis of Junctional Epidermolysis Bullosa Herlitz type. This test is critical for early intervention and management of the disease, providing essential information for genetic counseling and guiding treatment decisions.
The cost of the LAMB3 Gene Epidermolysis Bullosa Junctional Herlitz Type Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted with high precision and accuracy, ensuring reliable results for affected families. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring that patients receive the highest standard of care and support throughout the testing process.
The LAMB3 gene plays a crucial role in maintaining the structural integrity of the skin and mucous membranes. Mutations in this gene can lead to a rare genetic disorder known as Junctional Epidermolysis Bullosa (JEB) non-Herlitz type. This condition is characterized by fragile skin that easily blisters and wounds from minor friction or trauma, affecting the skin as well as internal organs in severe cases. The non-Herlitz type, while still serious, tends to have a milder course compared to the Herlitz type of JEB, with a better prognosis for longevity and quality of life.
To diagnose this condition, genetic testing of the LAMB3 gene is employed, which helps in identifying mutations responsible for the disorder. This test is crucial for accurate diagnosis, guiding treatment, and offering genetic counseling for affected families. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the LAMB3 gene. This test is an essential tool for healthcare professionals and families dealing with the challenges of Junctional Epidermolysis Bullosa non-Herlitz type, providing vital information for managing the condition effectively.
The "DSP Gene Epidermolysis Bullosa Lethal Acantholytic Genetic Test" is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the DSP gene, which are implicated in a severe form of skin disorder known as lethal acantholytic epidermolysis bullosa. This condition is characterized by extreme fragility of the skin and mucous membranes, leading to blister formation and skin erosion with minor trauma or friction. The test aims to identify individuals carrying mutations in the DSP gene, providing crucial information for diagnosis, management, and genetic counseling. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to perform this sophisticated genetic analysis. By pinpointing specific genetic alterations, the test facilitates personalized treatment plans and supports families in understanding their genetic landscape, particularly in terms of inheritance patterns and the risk of passing the condition to future generations.
The EXPH5 Gene Epidermolysis Bullosa Nonspecific Autosomal Recessive Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the EXPH5 gene. These mutations are associated with a form of epidermolysis bullosa, a group of rare genetic skin disorders characterized by blister formation in response to minor trauma. This specific test is crucial for individuals suspected of having the autosomal recessive variant of the condition, which is not linked to any specific type or severity of epidermolysis bullosa, making it a nonspecific test.
Epidermolysis bullosa can vary greatly in its presentation and severity, ranging from mild skin blistering to severe and life-threatening complications. Early and accurate genetic testing is vital for proper diagnosis, management, and genetic counseling for affected families. The test offered by DNA Labs UAE provides a comprehensive analysis of the EXPH5 gene to identify mutations that could lead to the disease.
The cost of the EXPH5 Gene Epidermolysis Bullosa Nonspecific Autosomal Recessive Genetic Test is set at 4400 AED. This investment covers the detailed laboratory analysis required to detect the presence of genetic abnormalities in the EXPH5 gene. By opting for this test, individuals and families gain essential insights into their genetic health, enabling informed decisions regarding management and treatment options. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, supporting patients and healthcare providers in the effective management of epidermolysis bullosa.
The KRT1 gene plays a crucial role in the health and integrity of the skin, and mutations in this gene can lead to a condition known as Epidermolytic Hyperkeratosis (EHK). EHK is a rare genetic skin disorder characterized by blistering and thickening of the skin. It usually manifests at birth or in early childhood and can vary in severity. The condition arises due to mutations affecting the keratin proteins in the skin, which are crucial for its strength and resilience.
To diagnose this condition accurately, a genetic test targeting the KRT1 gene can be performed. This test involves analyzing the DNA to identify mutations in the KRT1 gene that are known to cause Epidermolytic Hyperkeratosis. It is a critical step for affected individuals or families with a history of the condition, as it helps in confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding management and treatment strategies.
In the UAE, this specific genetic test for the KRT1 gene mutation associated with Epidermolytic Hyperkeratosis is available at DNA Labs UAE. The cost of the test is 4400 AED. The test is conducted in a state-of-the-art laboratory setting by professionals who specialize in genetic analyses. Results from this test can provide crucial information for affected individuals and their families, guiding them towards appropriate medical care and support.
